Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)

Francesco Saraceni , Myriam Labopin , Edouard Forcade , Nicolaus Kröger , Gerard Socié , Riitta Niittyvuopio , Jan Cornelissen , Hélène Labussière‐wallet , Didier Blaise (1) , Goda Choi , Jenny Byrne , Gaelle Guillerm , Tony Marchand , Jordi Esteve , Ali Bazarbachi , Bipin Savani , Attilio Olivieri , Arnon Nagler , Mohamad Mohty

1 CRCM - Centre de Recherche en Cancérologie de Marseille

Domains: Life Sciences [q-bio]; Immunology

Francesco Saraceni, Myriam Labopin, Edouard Forcade, Nicolaus Kröger, Gerard Socié, et al.. Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer Medicine, 2021, 10 (1), pp.23-33. ⟨10.1002/cam4.3593⟩. ⟨hal-03152855⟩